LIV Labs Inc. was awarded a $255,078 Project Grant from the National Science Foundation on January 15, 2022 to support research and development efforts concluding December 31, 2022. The grant was awarded under the NSF's Engineering program (CFDA #47.041), which seeks to improve quality of life and economic strength through engineering innovation and excellence.
Specifically, the funds will support LIV Labs' SBIR Phase I project to develop monitoring and treatment technologies for urinary incontinence in women. The NSF Engineering program aims to foster cutting-edge engineering research with potential for commercialization, such as new medical devices improving women's health. LIV Labs will leverage the grant to advance minimally invasive solutions for this widespread condition over the coming year.
Generated 1/7/24, 12:04 PM